Today
ChatGPT analysed a decade of my health data. Then I called my doctor
ChatGPT Health claims it can find patterns in your medical records. It graded my heart health an F, but experts said its output was “totally unacceptable”.
This Month
Doctors warn against this popular wellness trend
Hyperbaric oxygen therapy has become popular with biohackers focused on longevity, health and improved performance. But medical experts say there are risks.
CSL was our bluest blue chip. Now it looks chaotic
For the best part of a decade, the company was unimpeachable. But the sudden exit of chief executive Paul McKenzie underscores the new sense of chaos around the group.
Major study debunks statins side effect fears
Millions of Australians using statins to combat bad cholesterol can rest easier after scientists dispelled common concerns over side effects.
40 pills, 5 peptides: Why this CEO spends $70k a year on health
Andrew Raso’s daily regimen includes 40 supplements and a cocktail of experimental peptides. For him, it’s the price of high performance.
January
NSW’s first female governor, Dame Marie Bashir, dies at 95
The trailblazer served 14 years as the head of the state after a medical career in which she advocated for child, Indigenous and mental health causes.
The company repairing human bone with Kimberley pearl shells
Perth-based Orthocell has increased its stake in a local biomedical company producing bone repair products made from West Australian pearl shells.
‘Catastrophic’: Teenagers as young as 14 buying peptides online
Experts say peptides are now a bigger problem than steroids because more people use them and slick marketing on social media understates their risks.
Athletes were banned from taking it, now it’s a fitness craze
Claimed to provide chronic pain relief and Wolverine-like recovery, peptides are going mainstream – despite a lack of large-scale human trials.
Study finds weight loss drugs effective, but there’s a catch
An international review of weight-loss drug trials has found people who stop taking weight-loss medication return to original weight in less than two years.
The surprising new use for Ozempic
Some doctors are prescribing GLP-1 weight-loss drugs to help reduce cravings for alcohol and illicit drugs. But research on the benefits remains limited.
December 2025
All the changes coming on January 1
There may be more hurdles acquiring a business, but at least you can pay in cash. From merger reforms to mandated cash acceptance, here are the new January 1 rules.
Mayne Pharma under earnings pressure after failed takeover deal
Mayne says it made just $11.5 million in underlying earnings from July to November compared to $22.4 million over the same period last year.
Ozempic is already changing what we buy, from clothing to holidays
GLP-1 weight-loss drugs will play a huge role in society. Even now, they are reshaping the consumer economy and what companies are doing to adapt.
Blood test results on Whoop? Welcome to the future of wearables
Users can upload past blood test results to see how their habits and behaviours are affecting their biomarkers.
Cochlear-backed Epiminder overcomes ASX turmoil to hit the boards
The biotech specialises in epilepsy monitoring and prevention, but saw its shares slump on debut. The company says it is focused on its long-term potential.
Mystery global player flirted with battered Monash IVF, was rebuffed
The offshore interest is a reminder that Monash’s share price carnage, triggered by two diabolical embryo mix-ups in a year, has put it on the radar globally.
November 2025
Why women are turning to apps instead of doctors
Female health has been systemically relegated for decades. Influencers and entrepreneurs are filling the gap with simple narratives and purchasable solutions.
Why your exercise routine may not be enough to protect your brain
Dementia has overtaken heart disease to become Australia’s No.1 killer, yet as many as half of cases could be prevented by lifestyle changes.
Cochlear-backed Epiminder bullish about growth ahead of $325m listing
The company says its epilepsy treatment will be far more effective and less invasive than other options as it prepares for commercial production.
